Materia Malta Completes First Commercial Export of Medical Cannabis to Germany

  • Inaugural shipment landed in Germany, pre-orders from pharmacy customers to be fulfilled in the coming days
  • Materia Malta becomes the first company to export medical cannabis from Malta for sale in another country

LONDON, June 13, 2022 – Materia (the “Company”), a leading producer and distributor of medical cannabis in Europe, announces that its wholly-owned subsidiary Materia Malta Operating Ltd. (“Materia Malta”) has completed its first export of commercial medical cannabis from its EU GMP manufacturing site.

Read more

Materia Becomes Distribution Partner of Eurox Pharma for German-Produced Medical Cannabis Extracts

LONDON, August 17th, 2021 — Materia, a leading processor and distributor of medical cannabis and CBD wellness products across Europe, is pleased to announce that its wholly-owned subsidiary Materia Deutschland GmbH (“Materia Deutschland”), has entered into an agreement with German medical cannabis manufacturer Eurox Pharma GmbH (“Eurox Pharma”), becoming one of Eurox Pharma’s selected distribution partners for its medical cannabis extracts.

Read more

Materia and Saxonia Diagnostics Announce Exclusive Partnership for Distribution of Pharmacy Cannabis Testing Products

LONDON, May 5th, 2021 — Materia, a medical cannabis and wellness company focused on the European market, today announced that its wholly-owned subsidiary Materia Deutschland GmbH (“Materia Deutschland”) has entered into a partnership with German diagnostics company Saxonia Diagnostics GmbH (“Saxonia Diagnostics”) for the exclusive distribution of its branded cannabis testing products across Germany.

Read more

Materia Attains EU-GMP Certificate and Manufacturing and Import Licence in Germany

LONDON, Jan 28, 2021 /CNW/ — Materia, a medical cannabis and wellness company focused on the European market, is pleased to announce that its wholly-owned subsidiary Materia Deutschland GmbH (“Materia Deutschland” or the “Company”), has received its European Union Good Manufacturing Practices (“EU-GMP”) certificate as well as its manufacturing and import (“MIA”) licence. Following successful inspections by the local authorities, the Company was adjudged to comply with the high standard of production guidelines required to import, conduct manufacturing activities and batch release medical cannabis products.

Materia and Pure Ratios to Launch Award-Winning CBD Topicals into the UK Market

LONDON, July 9, 2020 /CNW/ – Materia (“Materia” or the “Company”), a medical cannabis and CBD wellness company focused on the European market, today announced an agreement with Pure Ratios Holdings Inc.(“Pure Ratios”), an award-winning CBD topical manufacturer and subsidiary of 4Front Ventures Corp(CSE:FFNT, OTCQX:FFNTF), to distribute and market its products across Europe.

Read more